MedTrace Logo

Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines

NCT02797028 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2016-06-13

No results posted yet for this study

Summary

The purpose of this study is to confirm the protective effect and mechanism of anthocyanins on hyperuricemia patients with Cardiovascular disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Anthocyanidins capsule

Continuous intervention for 1 years, detect the indicators in the intervention of 0,6,12 months

DIETARY_SUPPLEMENT

Placebo capsule

Continuous intervention for 1 years, detect the indicators in the intervention of 0,6,12 months

DRUG

Allopurinol

Continuous intervention for 1 years, detect the indicators in the intervention of 0,6,12 months

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Guangzhou General Hospital of Guangzhou Military Command

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-10-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02797028 on ClinicalTrials.gov